Published: 06th November, 2018
The co-leads of the CRUK Cambridge Centre Early Detection Programme, Professor Rebecca Fitzgerald and Dr Sarah Bohndiek, were honoured last night - Monday 5th November 2018 - at an awards ceremony taking place at the NCRI Cancer Conference in Glasgow.
Published: 17th October, 2018
The CRUK Cambridge Centre has a new Scientific Advisory Board, which is shared with the CRUK Cambridge Institute. All Centre members are cordially invited to meet our SAB on Friday 19 October 13.30-16.00, CRUK CI lecture theatre, at a special session about the Centre, which is taking place during the CRUK Cambridge Institute Retreat.
Published: 04th October, 2018
At the Conservative party conference this week, UK Prime Minister Theresa May announced a new cancer strategy for the country with the major focus on early cancer detection to improve cancer survival and bring it more into line with other developed nations. She indicated that cancer will form a central part of the new long-term plan for the NHS and that the key to boosting chances of surviving cancer is early diagnosis.
Published: 02nd October, 2018
The CRUK Cambridge Centre Early Detection fourth annual symposium will take place on Monday 28th January 2019 in the CRUK Cambridge Institute. We are delighted to invite PhD students and postdocs involved in all aspects of early detection research to submit abstracts to be considered for an oral and/or a poster presentation at the event.
Published: 19th September, 2018
This year's Cambridge Festival of Ideas shines the spotlight on health; talks about diet are featured and even a seminar on whether marriage is better for our health. The Early Detection programme contributes with a talk on the overdiagnosis of cancer.
Cancer screening comes under scrutiny during the CRUK Cambridge Centre Early Detection Programme event Cancer overdiagnosis: what is it? on 26th October. Speakers include Dr Stephen John, Hatton Lecturer in the Philosophy of Public Health and Dr Maryon McDonald, Fellow in Social Anthropology at Robinson College, Cambridge, who discuss some of the issues around cancer screening and diagnosis.
Published: 18th September, 2018
Congratulations to Dr Daniel Muñoz-Espín, Early Detection Programme Group Leader, and Dr Jim Korkola, Professor of Biomedical Engineering at OHSU, who have been awarded the CRUK-OHSU Project Award for their project entitled: Dissecting the role of the senescent secretome in tumorigenesis.
Published: 10th September, 2018
The BEST3 cytosponge clinical trial has recruited its ten-thousandth patient. Rebecca Fitzgerald explains more about the device in a live interview on BBC Look East.
Published: 04th September, 2018
Cancer Research UK have published their Annual Review for 2017/18 with a major focus on the Early Detection of Cancer. Pages 30-39 feature the chapter "Detecting and Diagnosing Cancer" which includes an article on Owlstone Medical and the PAN Cancer Trial that the company is running with the CRUK Cambridge Centre Early Detection Programme to detect cancer in breath samples.
The document also includes an interview with Sir Harpal Kumar, who stepped down as Chief Executive after more than 15 years with the charity. In his future vision he comments: “I hope it will include something in the area of early detection. We’re getting towards a breakthrough that’ll allow us to detect cancers at an early stage – including some of the most aggressive, dangerous ones – and that’s going to have a huge impact on survival.”
Please click here to open the report.
Published: 29th August, 2018
From September 2018 Cancer Research UK is removing the post-PhD time restrictions on applications for response-mode fellowships to ensure greater flexibility and equality.
Published: 22nd August, 2018
Trial aims to identify breath biomarkers to improve the early detection and diagnosis of different cancer types.
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, will run the PAN Cancer trial for Early Detection of Cancer in Breath. The large scale clinical study will evaluate the use of Owlstone Medical’s Breath Biopsy® platform for the early detection of multiple cancer types.